500 related articles for article (PubMed ID: 16503857)
41. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
Fortin A; Caouette R; Wang CS; Vigneault E
Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
Bernier J; Vermorken JB; Koch WM
J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
[TBL] [Abstract][Full Text] [Related]
43. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
44. Current radiation therapy management issues in oral cavity cancer.
Ballonoff A; Chen C; Raben D
Otolaryngol Clin North Am; 2006 Apr; 39(2):365-80. PubMed ID: 16580917
[TBL] [Abstract][Full Text] [Related]
45. Expanding role of the medical oncologist in the management of head and neck cancer.
Choong N; Vokes E
CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
[TBL] [Abstract][Full Text] [Related]
46. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
47. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
48. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
49. [Non surgical treatment approach for head and neck cancer].
Pointreau Y; Calais G
Rev Prat; 2006 Oct; 56(15):1677-83. PubMed ID: 17137253
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
51. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
52. The chemoradiation paradigm in head and neck cancer.
Seiwert TY; Salama JK; Vokes EE
Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
[TBL] [Abstract][Full Text] [Related]
53. Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.
Franchin G; Minatel E; Politi D; Gobitti C; Talamini R; Vaccher E; Savignano MG; Trovo M; Sulfaro S; Barzan L
Cancer; 2009 Jun; 115(11):2464-71. PubMed ID: 19280588
[TBL] [Abstract][Full Text] [Related]
54. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
Goguen LA; Posner MR; Tishler RB; Wirth LJ; Norris CM; Annino DJ; Sullivan CA; Li Y; Haddad RI
Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):526-31. PubMed ID: 16702569
[TBL] [Abstract][Full Text] [Related]
55. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
56. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.
Lu H; Peng L; Yuan X; Hao Y; Lu Z; Chen J; Cheng J; Deng S; Gu J; Pang Q; Qin J
Cancer Treat Rev; 2009 Jun; 35(4):345-53. PubMed ID: 19211192
[TBL] [Abstract][Full Text] [Related]
57. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
Kasperts N; Slotman BJ; Leemans CR; de Bree R; Doornaert P; Langendijk JA
Cancer; 2006 Apr; 106(7):1536-47. PubMed ID: 16518815
[TBL] [Abstract][Full Text] [Related]
58. Controversies in surgical management of the node-positive neck after chemoradiation.
Lango MN; Myers JN; Garden AS
Semin Radiat Oncol; 2009 Jan; 19(1):24-8. PubMed ID: 19028342
[TBL] [Abstract][Full Text] [Related]
59. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
60. Evolving strategies for combined-modality therapy for locally advanced head and neck cancer.
Posner M
Oncologist; 2007 Aug; 12(8):967-74. PubMed ID: 17766656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
